Illumina is a major provider of sequencing and array-based solutions for genetic and genomic analysis. The company has had a decent financial performance off-late in spite of macroeconomic challenges. They have seen a fantastic customer response to the recently launched NovaSeq X Series. It also launched the first-ever CE-marked and FDA-registered IVD high-throughput sequencer, NovaSeq 6000 DX. Driven by genetic disease testing and oncology testing, there has been a constant increase in clinical ....
